Pancreatic carcinogenesis-enhancement by cholecystokinin in the hamster-nitrosamine model.
The role of the pancreaticotrophic hormone cholecystokinin (CCK) in modifying the pancreatic response to carcinogen has been examined in the hamster-nitrosamine pancreatic cancer model. Exogenous CCK, 30 IDU kg-1, stimulated a maximal pancreatic secretory response when given intravenously and caused...
Main Authors: | Howatson, A. G., Carter, D. C. |
---|---|
Format: | Online |
Language: | English |
Published: |
1985
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1976814/ |
Similar Items
-
Structure-activity relationships in nitrosamine carcinogenesis.
by: Wishnok, J. S., et al.
Published: (1976) -
Role of cholecystokinin in dietary fat-promoted azaserine-induced pancreatic carcinogenesis in rats.
by: Appel, M. J., et al.
Published: (1992) -
Inhibitory effect of a cholecystokinin antagonist on pancreatic carcinogenesis after pancreatobiliary diversion.
by: Watanapa, P., et al.
Published: (1993) -
Histogenesis of pancreatic carcinogenesis in the hamster: ultrastructural evidence.
by: Flaks, B
Published: (1984) -
Effect of Nitrosamine Derivatives on Enzyme Concentrations in Rat Organs During Carcinogenesis
by: Hoch-Ligeti, Cornelia, et al.
Published: (1964)